VU534 structure
|
Common Name | VU534 | ||
|---|---|---|---|---|
| CAS Number | 923509-20-0 | Molecular Weight | 447.55 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H22FN3O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VU534VU534 is a NAPE-PLD activator, with an EC50 of 0.30 μM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 μM). VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study [1] . |
| Name | VU534 |
|---|
| Description | VU534 is a NAPE-PLD activator, with an EC50 of 0.30 μM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 μM). VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study [1] . |
|---|---|
| Related Catalog | |
| Target |
NAPE-PLD activator, with an EC50 of 0.30 μM |
| References |
| Molecular Formula | C21H22FN3O3S2 |
|---|---|
| Molecular Weight | 447.55 |
| InChIKey | RLHUIVPGYWWIQZ-UHFFFAOYSA-N |
| SMILES | Cc1cc(C)c2sc(NC(=O)C3CCN(S(=O)(=O)c4ccc(F)cc4)CC3)nc2c1 |